Failure of Primaquine Therapy for the Treatment of Plasmodium ovale Malaria
Author(s) -
Emmanuel Bottieau,
Alfons Van Gompel,
Willy Peetermans
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/497378
Subject(s) - primaquine , medicine , plasmodium ovale , malaria , protozoal disease , plasmodium vivax , chloroquine , intensive care medicine , virology , plasmodium falciparum , immunology
3. Barza M, Ioannidis JP, Cappelleri JC, Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 1996; 312:338–45. 4. Leibovici L, Paul M, Poznanski O, et al. Monotherapy versus beta-lactam–aminoglycoside combination treatment for Gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 1997; 41:1127–33. 5. Falagas ME. Monotherapy versus beta-lactam–aminoglycoside combination therapy for gram-negative bacteremia. Antimicrob Agents Chemother 1997; 41:2593–4. 6. Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia: a meta-analysis. Lancet Infect Dis 2004; 4:519–27.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom